The Japanese company Reprolife was founded in 2010 by the world-renowned clinical scientist Dr. Masashige Kuwayama, the pioneer behind revolutionary cryopreservation methods for human oocytes and embryos. Reprolife’s mission is to provide embryology laboratories worldwide with reliable tools to help millions of people realize their dream of becoming parents.
To achieve this mission, the company continuously invests in extensive clinical research and develops cutting-edge technologies in the field of assisted reproductive technologies (ART). The flagship Cryotec product line features unique, patented media and carriers designed for ultra-rapid vitrification and warming.
The crown achievement of Reprolife’s Cryotec technology is its documented 100% survival rate for biological material (including delicate Metaphase II oocytes and blastocysts). Due to the unique geometry of the cryo-straws and an optimized, low-toxicity cryoprotectant concentration, Reprolife products minimize the human factor in the embryology lab, setting the gold standard for vitrification in leading IVF clinics globally.
